Israeli DayTwo and Janssen Biotech Sign Partnership

DayTwo provides personalized dietary recommendations according to an intestinal bacteria profile, has announced the signing of a cooperation agreement with Janssen Biotech, a division of Johnson & Johnson. Particulars of the agreement were not disclosed, but it initially includes joint research, and probably joint development of a product at a later stage. The service provided by DayTwo is a diagnostic process for intestinal bacteria and an app that recommends to the user what food he personally should eat in order to maintain a balanced blood sugar level.

To read the full article, click here.


Author: Ethan Goldspiel

Comments are disabled.